anaphylaxis Archives

Fatal Pediatric Anaphylaxis Linked to Delays in Epinephrine Treatment

Apr 29, 2026 | Allergies, Ambulance & EMS, Pediatric Care

New studies suggest that airway and breathing failures are the primary causes of death in childhood food anaphylaxis, requiring a shift in emergency management protocols.

FDA Approves Age Limit Removal for Neffy Epinephrine Nasal Spray

Mar 27, 2026 | Allergies, FDA Approvals, Pediatric Care, US Pharmaceuticals

The updated label for the Neffy 1 mg dose allows children weighing at least 33 pounds to access the needle-free treatment regardless of age.

Epinephrine Nasal Spray Approved in China

Dec 30, 2025 | Allergies, Intl' Pharmaceuticals

The National Medical Products Administration (NMPA) in China granted approval for neffy 2 mg (epinephrine nasal spray) for the emergency treatment of Type 1 allergic reactions in adults and children weighing 30 kg or more.

First Fatal Case of AGS-related Anaphylaxis

Dec 1, 2025 | Allergies

This fatal case of delayed anaphylaxis raises concerns about lesser-known symptoms of food allergies and a growing prevalence of lone-star tick populations.

AAP Urges Food Allergy Preparation in Schools, Childcare Settings

Sep 29, 2025 | Allergies, Association News, Pediatric Care

The updated guidance from the AAP incorporates the latest national guidelines and laws, including support for stock epinephrine in schools.

Epinephrine Nasal Spray Approved in Japan

Sep 22, 2025 | Allergies, Intl' Pharmaceuticals

Regulators in Japan have cleared neffy epinephrine nasal spray for emergency use in adults and children for life-threatening allergies.

Positive Data for Neffy Epinephrine Nasal Spray

Sep 8, 2025 | Allergies, US Pharmaceuticals

New data indicates nearly 90% of patients experiencing anaphylaxis symptoms were successfully treated with a single dose of neffy nasal spray.

The Most Common School Medical Emergencies

Jun 30, 2025 | Ambulance & EMS, Pediatric Care

Two-thirds of school-based EMS calls led to hospital transport, highlighting the urgent need for school staff training and access to emergency medications like epinephrine, albuterol, and benzodiazepines.

Children Experiencing Anaphylaxis Spend Unnecessary Time in Hospitals

Jun 18, 2025 | Allergies, Ambulance & EMS, Emergency Room, Pediatric Care

The vast majority of children seeking emergency care for anaphylaxis could be safely discharged within four hours of hospital admission, according to data published in Lancet: Child and Adolescent Health.

Neffy Epinephrine Nasal Spray Available for Younger Children

May 9, 2025 | Allergies, Pediatric Care, US Pharmaceuticals

Neffy epinephrine nasal spray 1 mg is now available by prescription in the US for the treatment of Type I allergic reactions, including anaphylaxis, in pediatric patients weighing 15 kg to <30 kg.

Intestinal Immune Cell Prevents Food Allergies

Apr 9, 2025 | Allergies

A small population of immune cells in the intestine prevented allergic responses to food, suggesting that targeting such cells therapeutically could potentially lead to a new treatment for allergies.

FDA Approves Neffy Needle-Free Epinephrine Nasal Spray for Younger Children

Mar 7, 2025 | Allergies, FDA Approvals, Pediatric Care, US Pharmaceuticals

Neffy nasal spray provides a needle-free alternative for pediatric patients weighing between 15 and 30 kg who are at risk for severe allergic reactions.

College Dining Halls Lack Safety Measures for Food Allergies

Mar 7, 2025 | Allergies

College dining halls lack ingredient labels and emergency epinephrine, leading to higher risk of food allergy exacerbations and anaphylaxis.

FDA: Label Similarities Between Epinephrine Products Causing Dangerous Confusion

Jan 17, 2025 | Recalls & Advisories, US Pharmaceuticals

Similarities in bottle and packaging labels between unapproved nasal and FDA-approved injectable epinephrine products make it difficult to distinguish them, risking accidental injections of the nasal solution.

New Food Allergen Rules Require Sesame Labeling on Packaged Foods

Jan 14, 2025 | Industry & Regulatory News

The FASTER Act requires sesame to be labeled as a major food allergen on packaged foods, with FDA resources available to help consumers understand the new labeling requirements.